Transcriptional activation of heat shock protein 27 gene expression by 17β-estradiol and modulation by antiestrogens and aryl hydrocarbon receptor agonists

Journal of Molecular Endocrinology

Volumn 26, Issue 1, 2001, Pages 31-42

  Porter, W ^a   Wang, F ^a   Duan, R ^a   Qin, C ^a   Castro Rivera, E ^a   Kim, K ^a   Safe, S ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANTIESTROGEN; AROMATIC HYDROCARBON RECEPTOR; ESTRADIOL; HEAT SHOCK PROTEIN 27; MESSENGER RNA; N BUTYL 11 (3,17BETA DIHYDROXYESTRA 1,3,5(10) TRIEN 7ALPHA YL) N METHYLUNDECANAMIDE;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DRUG EFFECT; ESTROGEN ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; TRANSACTIVATION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; DNA PRIMERS; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; HEAT-SHOCK PROTEINS; HUMANS; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN; TRANS-ACTIVATION (GENETICS); TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0035128819     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0260031     Document Type: Article

References (92)

1. Quantitative enzyme-linked immunosorbent assay for the estrogen-regulated Mr 24 000 protein in human breast tumors: Correlation with estrogen and progesterone receptors
2. Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: Relation in response to chemotherapy and prognosis
3. Aromatase and its inhibitors in breast cancer treatment - Overview and perspective
4. Estrogen and aryl hydrocarbon responsiveness of ECC-1 endometrial cancer cells
5. Distribution of estrogen-induced protein with a molecular weight of 24 000 in normal and malignant human tissues and cells
6. Colocalization of estrogen and progesterone receptors with an estrogen-regulated heat shock protein in paraffin sections of human breast and endometrial cancer tissue
7. Biological and clinical implications of heat shock protein 27, 000 (Hsp27): A review
8. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro
9. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers
10. The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling
11. Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer
12. Mechanisms of transcriptional activation of bcl-2 gene expression by 17β-estradiol in breast cancer cells
13. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: Role of estrogen receptor Sp1 complex formation
14. Transcriptional activation of c-fos protooncogene by 17β-estradiol: Mechanism of aryl hydrocarbon receptor-mediated inhibition
15. Relationship of HSP27 and oestrogen receptor in hormone sensitive and insensitive cell lines
16. Estrogen induced synthesis of specific proteins in human breast cancer cells
17. Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7)
18. Estrogen and estrogen receptor antagonists stimulate transcription from the human retinoic acid receptor-α 1 promoter via a novel sequence
19. Ligands for peroxisome proliferator-activated receptor gamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice
20. Growth inhibition by retinol of a human breast carcinoma cell line in vitro and in athymic mice
21. Induction of the estrogen-regulated '24K' protein by heat shock
22. Identification of a motif within the 5′-regulatory region on pS2 which is responsible for Ap1 binding and TCDD-mediated suppression
23. Nuclear receptor coactivators
24. Bcl-2 and Hsp27 act at different levels to suppress programmed cell death
25. Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists
26. Retinoids and human cancer
27. Relationships between oestrogen receptor, epidermal growth factor receptor, ER-D5, and P24 oestrogen regulated protein in human breast cancer
28. Abundance of heat shock proteins (hsp89, hsp60, and hsp27) in malignant cells of Hodgkin's disease
29. Assisting spontaneity: The role of Hsp90 and small Hsps as molecular chaperones
30. The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors
31. Biochemical pharmacology of antiestrogen action
32. A current view of tamoxifen for the treatment and prevention of breast cancer
33. Endometrial carcinoma and tamoxifen: Clearing up a controversy
34. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells
35. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells
36. Localization of the oestradiol-binding and putative DNA binding domains of the human oestrogen receptor
37. Functional domains of the human estrogen receptor
38. Expression of the heat shock protein HSP27 in human ovarian cancer
39. Nuclear receptor cofactors as chromatin remodelers
40. The heat-shock proteins
41. Inhibition of prolactin receptor gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 human breast cancer cells
42. Basic guide to the mechanisms of antiestrogen action
43. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens
44. Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions
45. Antisense inhibition of the 27 kDa heat shock protein production affects growth rate and cytoskeletal organization in MCF-7 cells
46. Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death
47. Hsp27 as a switch between differentiation and apoptosis in murine embryonic stem cells
48. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo
49. Benzo[a] pyrene-resistant MCF-7 human breast cancer cells. A unique aryl hydrocarbon-nonresponsive clone
50. A cDNA for the estradiol-regulated 24K protein: Control of mRNA levels in MCF-7 cells
51. Lack of relationship between the expression of Hsp27 heat shock estrogen receptor-associated protein and estrogen receptor or progesterone receptor status in male breast carcinoma
52. Peptide antagonists of the human estrogen receptor
53. The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines
54. Basal regulatory promoter elements of the hsp27 gene in human breast cancer cells
55. The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients
56. Novel nuclear matrix protein HET binds to and influences activity of the HSP27 promoter in human breast cancer cell
57. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites
58. Estrogen receptor (ER) modulators each induce distinct conformational changes in ERα and ERβ
59. Action of 'pure' antiestrogens in inhibiting estrogen receptor action
60. Estrogenic and antiestrogenic compounds
61. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression
62. Functional synergy between the transcription factor Sp1 and the estrogen receptor
63. Transcriptional activation of insulin-like growth factor binding protein 4 by 17β-estradiol in MCF-7 cells: Role of estrogen receptor-Sp1 complexes
64. Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens - Studies using human estrogen receptor overexpressed in mammalian cells
65. Truncated estrogen receptor product-1 suppresses estrogen receptor transactivation by dimerization with estrogen receptors α and β
66. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds
67. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related environmental antiestrogens: Characterization and mechanism of action
68. Development of selective aryl hydrocarbon receptor modulators (SARMs) for treatment of breast cancer
69. Ligand-, cell- and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1) promoter elements
70. Molecular chaperones: Biology and prospects for pharmacological intervention
71. Estrogen-induced retinoic acid receptor α1 gene expression: Role of estrogen receptor-Sp1 complex
72. The Ah-receptor: Genetics, structure and function
73. Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: A clinicopathological and immunohistochemical study
74. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
75. Distinct effects on the conformation of estrogen receptor α and β by both the antiestrogens ICI 164,384 and ICI 182,780 leading to opposite effects on receptor stability
76. Transcriptional activation of transforming growth factor α by estradiol: Requirement for both a GC-rich site and an estrogen response element half-site
77. Protection of neuronal cells from apoptosis by Hsp27 delivered with a herpes simplex virus-based vector
78. The future of new pure antiestrogens in clinical breast cancer
79. Novel antioestrogens without partial agonist activity
80. A potent specific pure antioestrogen with clinical potential
81. Functional and physical interactions between the estrogen receptor-Sp1 and the nuclear aryl hydrocarbon receptor complexes
82. Transcriptional activation of E2F1 gene expression by 17β-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions
83. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
84. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions
85. Mechanistic aspects of dioxin action
86. Induction of cytochrome P4501A1: A model for analyzing mammalian gene transcription
87. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: Role of estrogen receptor-Sp1 interactions
88. Estrogen-modulated estrogen receptor pit-1 protein complex formation and prolactin gene activation require novel protein synthesis
89. Ligand structure-dependent differences in activation of estrogen receptor α in human HepG2 liver and U2 osteogenic cancer cell lines
90. Antiestrogenic activity of TCDD and related compounds
91. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression
92. CDK-independent activation of estrogen receptor by cyclin D1